Skip to Content

News

Medicare told to reassess premium hike for Alzheimer’s drug

By RICARDO ALONSO-ZALDIVAR Associated Press WASHINGTON (AP) — U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of enrollees this year. The increase was largely attributed to a pricey new Alzheimer’s drug with questionable benefits. Becerra’s directive on Monday comes days after drugmaker Biogen slashed the price of

Continue Reading

Medicare told to reassess premium hike for Alzheimer’s drug

By RICARDO ALONSO-ZALDIVAR Associated Press WASHINGTON (AP) — U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of enrollees this year. The increase was largely attributed to a pricey new Alzheimer’s drug with questionable benefits. Becerra’s directive on Monday comes days after drugmaker Biogen slashed the price of

Continue Reading